atai Life Sciences AG Announces Equity Investment in and Strategic Partnership...

Psychedelic Capitalism and Other Myths: Is the Joke On Us?

Psychotic- vs. Psychedelic-Induced Hallucinations: A Closer Look

Bright Minds Biosciences Announces Closing of $25.9 Million Unit Offering

Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces...

Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal...

Psyched Wellness Submits a Provisional Patent Application For AME-1

Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug...

Optimi Health Receives Health Canada NPN Product Licenses in Preparation for...

World Leading Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific...

Load more